Westech Industrial Expands Product Portfolio with United Electric Controls’ (UEC) Full Product Line in Western Canada

CALGARY, Alberta, Jan. 28, 2025 (GLOBE NEWSWIRE) — Westech Industrial Ltd., a trusted leader in industrial process solutions, is excited to announce the forthcoming addition of the complete line of UEC's products to its offerings for Western Canada. This strategic expansion builds on our existing relationship with UEC, where we currently provide their cutting-edge wireless […]

Skyharbour and JV Partner Orano Announces Extensive Exploration and Drilling Program in 2025 at Preston Uranium Project

(TSX-V:SYH),(OTC US:SYHBF),(Other OTC:SYHBF),(Boerse Frankfurt – Freiverkehr:SC1P), Vancouver, BC, Jan. 28, 2025 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), is planning a substantial 2025 exploration and drilling program at the 49,635 hectare Preston Uranium Project

Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP(TM)) Development Using iPSCs

(NASDAQ:HUMA), DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, and Pluristyx, Inc. today announced an expanded partnership. Pluristyx makes and sells PluriBank(TM) iPSC lines as part of their tools, technologies, and services to support the development

Marotta Controls Expands Capacity in Parsippany, Strengthening Commitment to Growth and the Local Community

MONTVILLE, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) — Marotta Controls, a leading provider of aerospace and defense systems, today announced the expansion of its operations to a newly upgraded facility in Parsippany, New Jersey. This strategic investment underscores Marotta Controls' commitment to fostering innovation, enhancing local economic development, and sustaining its remarkable growth over the

DIH Announces Strategic Partnership with Nobis Rehabilitation Partners

(NasdaqGM:DHAI), NORWELL, Mass. and ALLEN, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm

HII is Awarded Task Order for Approximately $296 Million to Support Global Air and Space Operations

(NYSE:HII), MCLEAN, Va., Jan. 28, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Mission Technologies division was awarded a task order valued at approximately $296 million to support U.S. Air Forces in Europe-Air Forces in Africa's (USAFE-AFAFRICA) air and space operations around the globe. Under the five-year Consolidated Mission Support task order,

Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference

(NASDAQ:ZBIO), WALTHAM, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced management's fireside chat presentation at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025,

NV5 to Host Fourth Quarter and Full Year 2024 Conference Call on Thursday, February 20th at 4:30pm ET

(NASDAQ:NVEE), HOLLYWOOD, Fla., Jan. 28, 2025 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, certification, and consulting solutions, will announce its financial results for the fourth quarter ended December 28, 2024, on Thursday, February 20, 2025, following the close of the markets. The Company will host an

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

(NASDAQ:CNTA), BOSTON and LONDON, Jan. 28, 2025 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences: Event: Guggenheim SMID Cap Biotech Conference Date: February 6, 2025Fireside Chat:

Dave Cantin Group Positions for Growth in 2025 with New Leadership Appointments and Promotions

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Dave Cantin Group (DCG), a leading mergers and acquisitions advisory company to retail automotive groups and their owners, has announced several strategic leadership advancements and new hires to support its growth in 2025 being fueled by an accelerating M&A environment as part of its ambitious growth strategy

Scroll to Top